ARYA Sciences Acquisition Corp II

ARYA Sciences Acquisition Corp II, trading under the ticker CERE, is a life sciences-focused blank check company sponsored by Perceptive Advisors, a healthcare-oriented investment firm. The SPAC completed its initial public offering in 2020 with a mandate to identify and acquire a target in the biopharmaceutical or broader life sciences sector. On January 18, 2024, the company filed a definitive merger proxy statement — Form DEFM14A — with the SEC, signaling that shareholders were being asked to vote on an announced business combination. The filing marks a late-stage milestone in the SPAC's transaction timeline. Visit SpacDesk and sign up for full data, filings, and analytics on CERE and hundreds of other SPAC deals.